2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Jianyu Rao, MD, professor and chief of Cytopathology, University of California, Los Angeles, discusses improving methods of early detection of ovarian cancer.
Jianyu Rao, MD, professor and chief of Cytopathology, University of California, Los Angeles, discusses improving methods of early detection of ovarian cancer.
In discussions regarding the relationship between genes and histology, physicians and pathologists are trying to determine if there is a way to improve early detection approaches, says Rao. One thing that Rao believes that there must be a better understanding of not only the BRCA genes, but other genes that may be involved in more sporadic cancers. Then, physicians can develop and refine non-invasive approaches like liquid biopsies.
The Hopkins group developed an algorithm to simultaneously analyze proteins and genes together with the hope of improving early detection. However, Rao notes that physicians and pathologists are still waiting to see if it will be clinically useful or not.